MAPKAPK2 and neoplasm: Regarding T cell activation and expansion, DC-targeted MK2 ablation did not affect either proliferation or CD25 upregulation on T cells and tumour-resident DCs of both genotypes failed to induce an overall T cell expansion in vitro (Supplementary Fig. 6b,c).